Persistence of Vascular Calcification after Reversal of Uremia

详细信息    查看全文

• 作者：Koba A. Lomashvili^&lowast ; ; Kelly E. Manning^&lowast ; ; M. Neale Weitzmann^&dagger ; ; ^&Dagger ; ; Valentin Nelea^§ ; ; Marc D. McKee^§ ; ; ^¶ ; ; W. Charles O'Neill^&lowast ; ; ^{woneill@emory.edu}
• 刊名：The American Journal of Pathology
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：187
• 期：2
• 页码：332-338
• 全文大小：1629 K
• 卷排序：187

文摘

The extent to which vascular calcification is reversible and the possible mechanisms are unclear. To address this, calcified aortas from uremic mice were transplanted orthotopically into normal mice, and the calcium content, histology, and minerals of the allografts were compared with the nontransplanted donor aorta. Calcium content decreased immediately after transplantation but remained constant thereafter, with 68% ± 12% remaining after 34 weeks. X-ray diffraction showed the presence of apatite in both donor aortas and allografts. Osteoclasts were absent in the allografts and there was no expression of the macrophage marker CD11b, the osteoclast marker tartrate-resistant acid phosphatase, or carbonic anhydrase II. The initial loss of calcium was less in heavily calcified aortas and was associated with an increase in the Ca/P ratio from 1.49 to 1.63, consistent with a loss of nonapatitic calcium. The results indicate that vascular calcification persists after reversal of uremia, because of a lack of active resorption of apatite. This failure to resorb established calcifications may contribute to the severity of vascular calcification and suggests that therapy should be aimed at prevention.